Can immune-enhancing nutrients reduce postoperative complications in patients undergoing esophageal surgery?

Diseases of the Esophagus

Volumn 21, Issue 8, 2008, Pages 708-711

  Fukuda, Takashi ^a   Seto, Y ^a   Yamada, K ^a   Hiki, N ^a   Fukunaga, T ^a   Oyama, S ^a   Yamaguchi, T ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Esophageal cancer; Immune enhancing nutrients; Infectious complication

Indexed keywords

ANTIBIOTIC AGENT; PREALBUMIN; RETINOID BINDING PROTEIN;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CATHETER INFECTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENTERIC FEEDING; ESOPHAGUS CANCER; ESOPHAGUS SURGERY; FEMALE; HUMAN; IMMUNE ENHANCING NUTRITION; INFECTION RATE; INFECTIOUS COMPLICATION; LABORATORY TEST; LENGTH OF STAY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURGICAL INFECTION;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIETARY SUPPLEMENTS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 56349158714     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2008.00861.x     Document Type: Article

References (10)

1. Heyland D K, Novak F, Drover J W, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286: 944-53.
2. Beale R J, Bryg D J, Bihari D J. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999; 27: 2799-805.
3. Heys S D, Walker L G, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: A meta-analysis of randomized controlled clinical trials. Ann Surg 1999; 229: 467-77.
4. Braga M, Gianotti L, Vignali A, Carlo V D. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002; 132: 805-14.
5. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002; 122: 1763-70.
6. Atkins B Z, Shah A S, Hutcheson K A et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg 2004; 78: 1170-6.
7. Bailey S H, Bull D A, Harpole D H et al. Outcomes after esophagectomy: A ten-year prospective cohort. Ann Thorac Surg 2003; 75: 217-22.
8. Dumont P, Wihlm J M, Hentz J G, Roeslin N, Lion R, Morand G. Respiratory complications after surgical treatment of esophageal cancer. A study of 309 patients according to the type of resection. Eur J Cardiothorac Surg 1995; 9: 539-43.
9. Ferguson M K, Durkin A E. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg 2002; 123: 661-9.
10. Griffin S M, Shaw I H, Dresner S M. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy: Risk factors and management. J Am Coll Surg 2002; 194: 285-97.